[ad_1]
Remdesivir was one of the drugs doctors used to treat the President of the United States, Donald Trump, after he was infected with the Corona virus, and it was shown in previous studies that it shortened the recovery time, and more than 50 countries did it. approved as a treatment for Corona or authorized its use for this purpose.
Gilead Sciences questioned the results of the solidarity experiment.
Referring to the brand of the drug, he said in a statement: "Viclor has been recognized as a standard for the care of hospitalized patients with the COVID-19 virus in the guidelines of many licensed national organizations.".
و .ضافت "We are disappointed that the WHO guidelines ignore this evidence at a time when cases are increasing dramatically around the world and PhyClure is trusted by physicians as the first antiviral treatment approved only for COVID-19 patients.".
The WHO Guidelines Development Group said its recommendation was based on a review of the evidence that included data from 4 international randomized trials involving more than 7,000 hospitalized patients with COVID-19.
“>
The committee stated in its guidelines: “The committee did not find sufficient evidence that remdesivir improved patient outcomes, such as reduced mortality, decreased need for ventilation, and shortened times to clinical improvement, among other things”.
These guidelines represent another setback for the drug, which attracted the world’s attention as a possible treatment for (Covid-19) in the summer after early trials showed some promising results.
In late October, Gilead lowered its revenue forecast for 2020, citing lower-than-expected demand and remdesivir sales difficult to forecast.
And that antiviral drug is currently one of only two drugs approved for use in treating Covid-19 patients worldwide, but a large trial led by the World Health Organization last month, known as the Solidarity Experience. , showed that it had no effect or effect whatsoever on mortality rates in 28 Days of positive exams or the period of hospital stay.
Remdesivir was one of the drugs that doctors used to treat the president of the United States, Donald Trump, after he caught the Corona virus, and it has been shown in previous studies that it shortened the recovery time, and more than 50 countries did approved as a treatment for Corona or authorized its use for this purpose.
Gilead Sciences questioned the results of the solidarity experiment.
“Vichlor has been recognized as the standard for hospital care of patients hospitalized with the Covid-19 virus in the guidelines of many authorized national organizations,” he said in a statement, referring to the drug’s trade name.
“We are disappointed that the WHO guidelines ignore this evidence at a time when cases are increasing dramatically around the world and PhyClure is trusted by physicians as the first antiviral treatment approved only for Covid-19 patients,” he added.
The WHO Guidelines Development Group said its recommendation was based on a review of the evidence that included data from 4 international randomized trials involving more than 7,000 hospitalized patients with COVID-19.
[ad_2]
